Skip to search boxSkip to navigationSkip to main content

Voriconazole: A second-generation triazole

  • P. H. Chandrasekar(corresponding author)
    ,
  • E. Manavathu
*Corresponding author for this work
  • Wayne State University
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 135-148 (14 pages)

Journal (Volume, Issue Number)

Drugs of Today (Volume 37, Issue 2)

Publication milestones

  • Published - 2001

Publication status

Published - 2001

ISSN

1699-3993

Publication IDs

  • Scopus: 0035073834

Publication metrics

Metrics

SciVal
FWCI
3.05
SciVal
Author count
2
SciVal
citations
97
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
10
Citation count
101